[Confidence Level: High] Hemastatx is a Swiss-Belgian biotechnology organization dedicated to treating severe and underserved bleeding disorders through the modulation of Von Willebrand Factor (VWF) degradation by targeting the enzyme .7
[Confidence Level: High] Hemastatx is a Swiss-Belgian biotechnology organization dedicated to treating severe and underserved bleeding disorders through the modulation of Von Willebrand Factor (VWF) degradation by targeting the enzyme .7
This is an extract of the full organization profile. To access the full company profile, .
Desktop only
The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.